GKB Ophthalmics held its 44th AGM, confirming no dividend for FY26 due to operating losses. Shareholders approved the re-appointment of K.G. Gupta and Cedric Lobo, while acknowledging K.G. Gupta's voluntary salary sacrifice to aid financial stabilization. The company will transition to reduced corporate governance compliance starting FY 2026-27 due to its net worth and equity capital size.
GKB Ophthalmics AGM Updates: Leadership Changes and Strategic Financial Shifts
No dividend was declared for FY 2025-26 due to reported operating losses.
Mr. K.G. Gupta voluntarily forfeited his Rs 3.60 lakh monthly salary to support financial stabilization.
Reader Takeaway: Management is prioritizing cash preservation through executive sacrifices, though significant global headwinds continue to challenge bottom-line profitability.
What just happened
GKB Ophthalmics Ltd concluded its 44th Annual General Meeting in Goa on August 25, 2026. All resolutions were approved by shareholders, confirming the re-appointment of K.G. Gupta as Chairman and Managing Director for a three-year term, and Cedric Lobo as Whole-time Director for two years. The meeting highlighted significant operational strain, with the board citing global geopolitical tensions and volatile raw material costs as primary drivers for the year's losses.
Why this matters
The decision to skip dividends underscores the company's current focus on liquidity. Notably, the Board acknowledged a significant gesture from Mr. K.G. Gupta, who has voluntarily opted to forego his Rs 3.60 lakh monthly basic salary starting January 1, 2026, to aid the firm's financial stability. Shareholders also set significant Related Party Transaction limits, totaling Rs 42 crore combined for GKB Vision Private Limited and Lensco.
Corporate Governance Status
Beginning in FY 2026-27, GKB Ophthalmics will be exempt from certain mandatory corporate governance provisions under SEBI Listing Regulations. This follows a three-year period where both the company's paid-up equity share capital and net worth have fallen below the regulatory thresholds of Rs 10 crore and Rs 25 crore, respectively.
What to track next
Investors should closely watch for signs of operational recovery. The ability of the company to manage supply chain costs and leverage its approved related-party transaction arrangements will be critical to returning to profitability and potentially reinstating dividend payouts in the future.